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A B S T R A C T
Mitochondrial NADP+-dependent isocitrate dehydrogenase 2 (IDH2) is a major NADPH-producing enzyme
which is essential for maintaining the mitochondrial redox balance in cells. We sought to determine whether
IDH2 deﬁciency induces mitochondrial dysfunction and modulates auditory function, and investigated the
protective potential of an antioxidant agent against reactive oxygen species (ROS)-induced cochlear damage in
Idh2 knockout (Idh2−/−) mice. Idh2 deﬁciency leads to damages to hair cells and spiral ganglion neurons (SGNs)
in the cochlea and ultimately to apoptotic cell death and progressive sensorineural hearing loss in Idh2−/−mice.
Loss of IDH2 activity led to decreased levels of NADPH and glutathione causing abnormal ROS accumulation and
oxidative damage, which might trigger apoptosis signal in hair cells and SGNs in Idh2−/−mice. We performed ex
vivo experiments to determine whether administration of mitochondria-targeted antioxidants might protect or
induce recovery of cells from ROS-induced apoptosis in Idh2-deﬁcient mouse cochlea. MitoQ almost completely
neutralized the H2O2-induced ototoxicity, as the survival rate of Idh2−/− hair cells were restored to normal
levels. In addition, the lack of IDH2 led to the accumulation of mitochondrial ROS and the depolarization of ΔΨm,
resulting in hair cell loss. In the present study, we identiﬁed that IDH2 is indispensable for the functional
maintenance and survival of hair cells and SGNs. Moreover, the hair cell degeneration caused by IDH2 deﬁciency
can be prevented by MitoQ, which suggests that Idh2−/− mice could be a valuable animal model for evaluating
the therapeutic eﬀects of various antioxidant candidates to overcome ROS-induced hearing loss.
1. Introduction
The balance between reactive oxygen species (ROS) production and
antioxidant defenses is essential for maintaining cellular homeostasis.
Under physiologic conditions, cells maintain redox balance through the
generation and elimination of ROS [1]. Mitochondria are a major
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endogenous source of cellular ROS, where O2− is generated by electron
leakage from complex I to IV of the electron-transport chain [2,3].
Various enzymatic (superoxide dismutase (SOD) or glutathione perox-
idase (GPx)) and nonenzymatic (vitamin C or E) antioxidant systems
contribute to eliminating ROS and maintaining redox homeostasis.
Excessive ROS constantly attack lipids, proteins, and DNA in cells,
leading to severe and irreversible oxidative damage. Several ROS-re-
lated studies have demonstrated that increased oxidative damage plays
a crucial role in a variety of pathologic conditions, including cancer,
neurodegenerative diseases, and aging [4,5].
Hearing loss, a common sensory disorder that is caused by diﬀerent
genetic or environmental factors, is also triggered by the accumulation
of continuous oxidative stress with age [6]. Ototoxic drugs, noise ex-
posure, and aging are common environmental factors that disrupt in-
tracellular redox balance [6–8], and pathogenic mutations in the genes
that are involved in the redox system are the major genetic causes of
ROS-induced hearing loss. For example, methionine sulfoxide reductase
B3 (MsrB3) that speciﬁcally reduces methionine-R-sulfoxide of proteins
to methionine, is the causative gene of autosomal recessive non-syn-
dromic hearing loss DFNB74 [9]. Because methionine residues in pro-
teins are a major target of oxidization to methionine sulfoxide by ROS,
this enzyme is responsible for preserving the biological activity of
proteins after oxidative damage due to ROS [10,11]. In addition, since
cochlear cells are highly sensitive to disturbances in energy metabo-
lism, mitochondrial decay may particularly aﬀect the cochlea. Muta-
tions in mitochondrial DNA (mtDNA) or in several nuclear genes coding
mitochondrial proteins have been known to be associated with pro-
gressive hearing loss [12]. Major mtDNA mutations occur in the genes
encoding mitochondrial oxidative phosphorylation complexes and lead
to mitochondrial dysfunction. Hyperaccumulation of mitochondrial
ROS decreased mitochondrial membrane potential, and activated
apoptotic pathways, eventually causing hair cell death.
Mitochondrial NADP+-dependent isocitrate dehydrogenase 2
(IDH2) catalyzes the oxidative decarboxylation of isocitrate to α-ke-
toglutarate, synthesizing NADPH. In mitochondria, the redox balance is
mainly determined by the ratios of several redox couples, such as re-
duced glutathione (GSH)/oxidized glutathione (GSSG) and thioredox-
inred/thioredoxinoxid. The GSH/GSSG couple has been considered the
primary determinant of the intracellular redox state, and the GSH/
GSSG ratio is regulated by antioxidant enzymatic scavengers, including
glutathione reductase (GR) and GPX [13,14]. Given the role of NADPH
as the electron donor for GR-mediated GSH generation, IDH2, which
increases NADPH levels by converting NADP+ to NADPH, has been
highlighted as a major contributor to the antioxidant defense system in
various tissues and cells [15–21]. It has been shown that IDH2 protects
organs against various diseases, including cancer, skin pigmentation
[22] and renal dysfunction [23]. In addition, endothelium-dependent
vasorelaxation is impaired, and the concentration of bioavailable NO is
decreased in the aortic ring in Idh2 knockout (Idh2−/−) mice [24].
However, the physiological association between Idh2 and auditory
function and its underlying mechanisms are not fully understood.
Therefore, we sought to determine whether Idh2 deﬁciency induces
mitochondrial dysfunction and modulates auditory function, and in-
vestigated the protective potential of an antioxidant agent against ROS-
induced cochlear damage in Idh2−/− mice.
2. Materials and methods
2.1. Animals
Idh2−/− mice were bred [19], and mice of their background strain
(C57BL/6N) were used as a wild-type (Idh2+/+) control. For genetic
identiﬁcation of the Idh2−/− mice, tail DNA genotyping was per-
formed. Mice were allowed free access to water and standard mouse
chow. Temperature (23 ± 2 °C), humidity (50 ± 5%) and a daily 12 h
light–dark cycle were maintained in the Central Laboratory Animal
Facility of Kyungpook National University. All animal procedures were
conducted in accordance with the Institutional Animal Care guidelines
issued by the Committee of Animal Research at Kyungpook National
University (2017–0104).
2.2. Reverse-transcription polymerase chain reaction (RT-PCR)
RNA was extracted from the inner ear of mice using an RNeasy®
Mini Kit (Qiagen, Hilden, Germany) in accordance with the manufac-
turer's instructions. RNA was reverse transcribed to cDNA using a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster
City, CA, USA) according to the manufacturer's protocol. cDNAs were
PCR-ampliﬁed. The glyceraldehyde 3-phosphate dehydrogenase (Gapdh)
gene was used as an internal control.
2.3. Western blot analysis
The whole-cell lysates or tissue homogenates (20 µg) prepared from
cochlear explants was used for western blotting. The proteins were
detected using the appropriate primary and secondary antibodies. After
a series of washes, membranes were developed using an enhanced
chemiluminescent detection system. Values are normalized to β-actin
(loading control). The primary antibodies used in this study were as
follows: rabbit polyclonal anti-IDH2 (1:1000; Novus Biologicals,
Littleton, CO, USA), rabbit polyclonal anti-OXPHOS complex subunits:
NDUFA9 (1:500; Thermo Fisher Scientiﬁc, Rockford, IL, USA), SDHA
(1:500; Thermo Fisher Scientiﬁc, Rockford, IL, USA), UQCRC2 (1:5000;
Thermo Fisher Scientiﬁc, Rockford, IL, USA), COX4 (1:500; Thermo
Fisher Scientiﬁc, Rockford, IL, USA) and ATP5A1 (1:1000; Thermo
Fisher Scientiﬁc, Rockford, IL, USA) and rabbit polyclonal anti-β actin
(1:2000; Cell Signaling Technology, Danvers, MA, USA). Goat anti-
rabbit-lgG-HRP was used as the secondary antibody (1:2000; Cell
Signaling Technology, Danvers, MA, USA).
2.4. Auditory brainstem response (ABR) measurement
Mouse auditory function was assessed by measuring ABR with an
ABR workstation-System 3 (Tucker Davis Technology, Alachua, FL,
USA), as previously described [25]. Auditory function was measured
with click stimuli and tone burst sound frequencies of 8, 16, and
32 kHz, and acoustic thresholds of sound pressure level (SPL) were
determined using BioSigRP software (Tucker Davis Technology, Ala-
chua, FL, USA).
2.5. Immunoﬂuorescence and histological analysis
Inner ears were harvested and ﬁxed with 4% paraformaldehyde
(PFA) in phosphate-buﬀered saline (PBS). The ﬁxed inner ear tissues
were embedded in paraﬃn. Paraﬃn-embedded tissues were serially
sectioned at 7 µm and then subjected to immunoﬂuorescence analysis
or hematoxylin-eosin (H&E) staining. The paraﬃn sections were in-
cubated for 1 h at 65 °C, deparaﬃnized with xylene, and rehydrated
using a graded ethanol series. The tissue sections were permeabilized
with 0.1% Triton X-100 in 1X PBS (PBS-Tx) for 30min and blocked
using a blocking solution containing 5% normal goat serum (NGS) in
PBS-Tx for 1 h at room temperature (RT). The sections were then in-
cubated overnight at 4 °C with rabbit anti-NADPH (Biorbyt, Cambridge,
UK) and mouse anti-COX4 (Abcam, Cambridge, UK). After washing
with PBS, the tissue sections were incubated for 1 h at RT with sec-
ondary antibodies. The secondary antibodies used for immuno-
ﬂuorescence were Alexa Fluor 488-conjugated goat anti-mouse IgG and
555-conjugated goat anti-rabbit IgG (Thermo Fisher Scientiﬁc,
Rockford, IL, USA). 4′-6-Diamidino-2-phenylindole (DAPI, 1 µg/mL)
was used to visualize nuclei.
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2.6. Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay
To assess apoptotic cell death in the inner ear, we evaluated DNA
fragmentation using the TUNEL assay according to the manufacturer's
protocol (Roche Biochemicals, Mannheim, Germany). Paraﬃn-em-
bedded inner ear sections were deparaﬃnized and rehydrated. They
were then permeabilized with PBS-Tx and 0.1% sodium citrate in dis-
tilled water for 20min at RT and stained with TUNEL working solution
for 1 h at 37 °C, without light. The specimens were mounted on glass
slides using ﬂuoromount (Sigma-Aldrich, Saint Louis, MO, USA) and
visualized using a Zeiss Axio Imager A2 ﬂuorescence microscope (Carl
Zeiss, Oberkochen, Germany).
2.7. Enzyme assays
Supernatants from homogenized mitochondrial pellets were each
added to 1mL of 40mM tris buﬀer (pH 7.4) containing NADP+ (2mM),
MgCl2 (2 mM), and isocitrate (5 mM). IDH2 activity was measured by
monitoring NADPH production at 340 nm at 25 °C. One unit of IDH2
activity was deﬁned as the amount of enzyme needed to catalyze the
production of 1mmol of NADPH per minute. Total GSH levels and the
GSH/GSSG ratio were measured using a commercially available GSH/
GSSG Ration Detection Assay Kit (Abcam, Cambridge, UK) according to
the manufacturer's instructions.
2.8. Culture and histological evaluation of mouse cochlear explants
Primary cochlear explants were prepared from postnatal day (P) 3
mice. The dissected organs of Corti were incubated with culture
medium composed of high-glucose Dulbecco's modiﬁed Eagle's medium
(DMEM; HyClone, Logan, UT, USA) containing 10% fetal bovine serum
(FBS; HyClone, Logan, UT, USA) and ampicillin (10 μg/mL) in a hu-
midiﬁed atmosphere of 5% CO2 at 37 °C. After 16 h incubation, organs
of Corti were treated with 500 nM MitoQ in dimethyl sulfoxide (DMSO)
or 500 nM decyl triphenylphosphonium (dTPP) in DMSO provided by
Prof. Michael P. Murphy. At the same time, some groups were treated
with 5 μM rotenone (Sigma-Aldrich, Saint Louis, MO, USA) or 10 μM
antimycin A (Sigma-Aldrich, Saint Louis, MO, USA) diluted in culture
medium for 1 h. After 1 h incubation, 0.05mM hydrogen peroxide
(H2O2) was added.
2.9. Histological evaluation of mouse cochlear explants
At the end of the 5-day incubation period, all cochlear explants were
washed with PBS, ﬁxed with 4% PFA in PBS for 15min, and permea-
bilized for 30min at RT. Permeabilized samples were blocked with 5%
NGS diluted in PBS-Tx for 1 h at RT and then stained with Alexa Fluor®
488 or 555-conjugated phalloidin (1:1000; Invitrogen, Eugene, OR,
USA) in PBS-Tx for 3 h at RT. The specimens were rinsed three times
with PBS and mounted on glass slides using ﬂuoromount (Sigma-
Aldrich, Saint Louis, MO, USA). For immunohistochemical quantiﬁca-
tion, the inner hair cells (IHCs) and outer hair cells (OHCs) were se-
parately counted along the 6 regions from the middle of each cochlear
explant. Perfectly shaped hair cells in each region, with a length of
200 µm of basilar membrane, were counted. Each experiment was
performed independently and repeated at least three times.
2.10. Determination of mitochondrial ROS levels
MitoSOX-red (Molecular Probes, Eugene, OR, USA) is a ﬂuorogenic
indicator of superoxide generated speciﬁcally from mitochondria [26].
At the end of the 3-day incubation period, all cochlear explants were
washed with PBS and stained with 5 μM MitoSOX-red for 10min in a
humidiﬁed atmosphere of 5% CO2 at 37 °C. After washing with PBS, the
specimens were visualized using a Zeiss Axio Imager A2 ﬂuorescence
microscope (Carl Zeiss, Oberkochen, Germany).
2.11. Determination of mitochondrial membrane potential (ΔYm)
Mitochondrial membrane potential was estimated using the cationic
ﬂuorescent dye MitoProbe™ JC-1 (Invitrogen, Eugene, OR, USA) ac-
cording to the manufacturer's instructions. At the end of the 3 or 5-day
incubation period, all cochlear explants were washed with PBS and
incubated with 2 μM JC-1 for 50min in the dark. To conﬁrm the sen-
sitivity of JC-1, the cochlear explants were not treated with any drugs,
50 μM carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was added
before treatment with JC-1, and the samples were incubated. If the cells
have a normal range of mitochondrial membrane potentials, ﬂuores-
cence emission shift from green to red.
2.12. Statistical analyses
Statistical analyses were performed using 2-tailed Student's t-tests;
P < 0.05 was considered statistically signiﬁcant. The data were ana-
lyzed by comparing treated and untreated contralateral structures or by
comparing treated and control mice.
3. Results
3.1. Loss of Idh2 leads to progressive sensorineural hearing loss in mice
Because inner ear expression of the Idh2 gene in the Idh2−/− mice
[27] has not been conﬁrmed in previous studies, we ﬁrst examined Idh2
expression in the inner ear and conﬁrmed that Idh2 mRNA and protein
expression was completely absent in the inner ear of Idh2−/− mice,
while it was abundantly expressed in Idh2+/+ mice (Supplementary
Fig. 1). The changes in the hearing threshold of Idh2+/+ and Idh2−/−
mice were then followed-up for 12 months by ABR tests with a click
stimulus and frequency-speciﬁc stimuli at 8, 16, and 32 kHz to in-
vestigate whether lack of Idh2 aﬀects normal hearing function (Fig. 1).
No signiﬁcant diﬀerences were found between Idh2+/+ and Idh2−/−
mice until 2 months after birth. However, after 3 months of age, the
hearing ability of the Idh2−/− mice began to deteriorate signiﬁcantly
compared with the hearing ability of Idh2+/+ mice, eventually re-
sulting in profound hearing loss after 10 months of age. The ABR
threshold gap between the Idh2+/+ and Idh2−/− mice gradually in-
creased at all frequencies (Supplementary Fig. 2), which indicates that
Idh2 deﬁciency leads to the continuous accumulation of hearing da-
mage with age. Moreover, even if this pattern of hearing loss was
consistent at all tested frequencies, the progression of hearing loss was
more rapid at mid (16 kHz) and high (32 kHz) frequencies than at low
(8 kHz) frequencies (Supplementary Fig. 2). This result indicates that
Idh2 deﬁciency leads to progressive sensorineural hearing loss in mice,
suggesting an important role of Idh2 in the auditory pathway.
3.2. IDH2 deﬁciency causes damage to hair cells and spiral ganglion
neurons (SGNs), leading to apoptosis
To investigate the immediate cause of hearing loss in Idh2−/− mice,
we ﬁrst examined the histological features of cochlear sections from
Idh2+/+ and Idh2−/− mice through H&E staining at 2 months of age
when there was no diﬀerence in ABR threshold between Idh2+/+ and
Idh2−/− mice and at 10 months of age when Idh2−/− mice showed
profound hearing loss at 16 and 32 kHz. In the cochlea of 2-month-old
mice, no distinguishable diﬀerences were detected between Idh2+/+
and Idh2−/− mice (Supplementary Fig. 3). In contrast, at 10 months of
age, obvious damage was observed in the organ of Corti and in the
SGNs in Idh2−/− cochlea (Fig. 2A). While both the inner and outer hair
cells from 10-month-old Idh2+/+ cochlea were intact, Idh2−/− cochlea
had morphological degeneration of the hair cells (Fig. 2A d-f, d′-f′).
Moreover, the most noticeable diﬀerence was found in the spiral
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ganglion, which showed evident loss of SGNs in the Idh2−/− cochlea
(Fig. 2A g-i, g′-i′). Quantitative analysis conﬁrmed that the loss of SGNs
signiﬁcantly diﬀered from apical to basal cochlear turns, whereas there
were no signiﬁcant diﬀerences in stria vascularis thickness and spiral
ligament area between Idh2+/+ and Idh2−/− cochlea (Fig. 2B). Im-
portantly, all these damages were more severe in the basal turn than in
the apical turn, which was consistent with the mid- and high-frequency-
dominant progression of hearing loss observed in the ABR test of Idh2−/
−mice. A highly increased number of TUNEL-positive cells in the organ
of Corti and the SGNs of Idh2−/− cochlea suggested that Idh2 deﬁ-
ciency causes apoptosis of hair cells and SGNs, eventually leading to
hearing loss (Fig. 3).
3.3. Loss of IDH2 function results in excessive accumulation of ROS due to
decreased NADPH levels and disrupted GSH/GSSG balance in mouse
cochlea
Considering the IDH2 function in mitochondria, we next in-
vestigated intracellular levels of NADPH and total ROS using im-
munoﬂuorescence, IDH2 enzyme activity assay, and 3,3′-diamino-
benzidine (DAB) staining in Idh2+/+ and Idh2−/− cochlea at 10
months of age, to determine if the antioxidative function of IDH2 is
indispensable for the functional maintenance and survival of hair cells
and SGNs (Fig. 4). The immunoﬂuorescence staining results indicated
that the ﬂuorescence signal for NADPH was detected throughout the
entire inner ear sections in both Idh2+/+ and Idh2−/− mice. However,
the signal intensity was much weaker in Idh2−/− cochlea than in
Idh2+/+ (Fig. 4A). This result was conﬁrmed by an in vitro enzymatic
activity assay, which measures NADPH production by IDH2 in NADP+
containing inner ear lysates from Idh2+/+ and Idh2−/− mice. The re-
lative eﬃciency of NADPH production in IDH2-deﬁcient inner ear ly-
sate was approximately 12% compared to Idh2+/+ cochlea (Fig. 4B).
Consequently, the intracellular level of GSH that is generated by the
NADPH-driven reduction in GSSG was signiﬁcantly decreased, leading
to an increase in the GSSG/GSH ratio, which indicated disruption of the
redox balance in the IDH2-deﬁcient inner ear (Fig. 4C). Finally, in-
creased intracellular ROS levels in Idh2−/− cochlea, including in the
organ of Corti and the spiral ganglia, was detected by DAB staining
(Fig. 4D). These results demonstrated that loss of IDH2 activity de-
creased the levels of NADPH and GSH, leading to redox imbalance,
which might cause apoptosis of hair cells and SGNs by abnormal ROS
accumulation in Idh2−/− mice.
3.4. Mitochondria-targeted antioxidant MitoQ prevents H2O2-induced
ototoxicity in Idh2−/− cochlea
Our in vivo study demonstrated that the most direct cause of hearing
loss observed in Idh2−/− mice was the accumulation of excessive ROS,
leading to apoptosis of hair cells and SGNs. Because IDH2 is a major
NADPH-producing enzyme in the mitochondrial redox system and ROS-
induced mitochondrial damage directly aﬀects cell survival [1], we
hypothesized that the administration of eﬀective mitochondrial
Fig. 1. ABR hearing thresholds of the Idh2+/+ and Idh2−/−mice as a function of age. The changes in the hearing threshold of Idh2+/+ (white circle with dotted
line, n=6) and Idh2−/− (black circle with solid line, n=18) mice were represented using line graphs. The ABR thresholds were measured for 12 months with a click
(A) and tone burst (8, 16, and 32 kHz) (B, C and D) stimuli. Data are shown as the means± SEM. *p < 0.05, **p < 0.005.
Y.-R. Kim et al. Redox Biology 20 (2019) 544–555
547
antioxidants might protect or promote the recovery of cells from ROS-
induced apoptosis in Idh2-deﬁcient mouse cochlea. To verify our hy-
pothesis, we induced acute oxidative stress in Idh2+/+ and Idh2−/−
mouse cochlear explants by treatment with H2O2, leading to ROS-in-
duced cell damage. Before the addition of H2O2, the mitochondria-
targeted antioxidant, MitoQ, was pre administered to the cochlear ex-
plants to examine whether it could protect Idh2-deﬁcient hair cells from
H2O2 (ROS)-induced apoptosis. First, Idh2+/+ cochlear explants were
treated with 0.025, 0.05, or 0.1mM H2O2 for 5 days to determine the
optimal toxic dose, and hair cell damage was visualized by im-
munostaining of cochlear whole-mount with phalloidin. Treatment
with H2O2 led to the degeneration of stereocilia and the loss of hair cells
in a dose-dependent manner, and the damage gradually became more
severe from the apical to basal turn (Supplementary Fig. 4). Finally, a
0.05mM concentration that contributed to obvious but mild hair cell
defects in Idh2+/+ was selected as the H2O2 treatment dose for all
subsequent experiments.
The protective eﬀect of MitoQ against H2O2-induced hair cell loss
was investigated by pre-treatment with 500 nM MitoQ, followed by
post-treatment with 0.05mM H2O2 in Idh2+/+ and Idh2−/− cochlear
explants. When the cochlear explants were exposed to only H2O2 and a
negative control of MitoQ, dTPP, Idh2-deﬁcient cochlear explants
exhibited highly severe damage in both inner and outer hair cells
showing disarrangement of hair cell rows and stereocilia degeneration,
while only mild hair cell migration was observed without noticeable
loss of hair cells in Idh2+/+ cochlea (Fig. 5A). This means that loss of
IDH2 function makes hair cells much susceptible to H2O2-induced
oxidative stress. However, MitoQ pre-treatment before adding H2O2
remarkably reduced hair cell loss in Idh2−/− cochlear explants, sug-
gesting that the mitochondrial antioxidative eﬀect of MitoQ protects
hair cells from H2O2-induced degeneration even when the cells are
deﬁcient in IDH2. Treatment with only MitoQ showed no evident cy-
totoxicity. These results were quantitatively measured by counting the
average number of stereocilia-positive hair cells in the 200-μm cochlear
region of the middle turn. In Idh2+/+ cochlea, neither H2O2-induced
damage nor MitoQ-dependent recovery of hair cells were signiﬁcant. In
contrast, in Idh2−/− cochlea, hair cell loss by H2O2 treatment was
highly signiﬁcant and was dramatically recovered by pre-treatment
with MitoQ (Fig. 5B). Importantly, although H2O2 treatment led to a
signiﬁcant decrease in hair cell survival in Idh2−/− cochlea compared
with Idh2+/+ cochlea (Fig. 5C), MitoQ almost completely neutralized
the H2O2-induced ototoxicity, contributing to restoration of the survival
rate of Idh2−/− hair cells to normal levels in both inner and outer hair
cells. This phenomenon was more prominent in OHCs than in IHCs. This
Fig. 2. Histological evaluation of cochlea from Idh2+/+ and Idh2−/− mice. (A) H&E staining was performed in the inner ear sections of Idh2+/+ (n=4) and
Idh2−/− (n=6) mice at 10 months of age. SG, spiral ganglion; SV, stria vascularis; SL, spiral ligament. Scale bars; 100 µm in (i′) and 20 µm in (c′ and f′). The
arrowheads point to three rows of outer hair cells, and the asterisk (*) indicates an inner hair cell. (B) The thickness of the stria vascularis, the mean area of the spiral
ligament, and the density of spiral ganglion neurons at apical, middle, and basal turns of cochlea were measured in the inner ear sections of Idh2+/+ (blue circles)
and Idh2−/− (red squares) mice at 10 months of age. ***p < 0.001; n.s., nonsigniﬁcant.
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result strongly suggests that IDH2 plays an indispensable role in re-
moving mitochondrial ROS, which is essential for the functional
maintenance and survival of hair cells. Furthermore, it suggests a strong
possibility that the protective or therapeutic eﬀect of various mi-
tochondria-targeted antioxidant reagents could be examined to over-
come mitochondrial ROS-induced ototoxicity using this model.
Direct evidence of mitochondrial damage due to oxidative insults in
Idh2−/− mouse cochlea was conﬁrmed by analyzing mitochondrial
ROS levels and ΔΨm in cochlear explants using the mitochondrial ROS
indicator MitoSOX-red and the mitochondria-accumulated ﬂuorescent
dye MitoProbe JC-1, respectively. The data showed that H2O2 stimuli
led to increased mitochondrial ROS levels (Fig. 6A) and depolarization
of ΔΨm (Fig. 6B) in Idh2−/−mouse cochlea 3 days after H2O2 treatment,
but this damage was eﬀectively prevented by MitoQ. These results
provide strong evidence that the antioxidative activity of MitoQ pro-
tects hair cells from H2O2 by reducing ROS levels and by maintaining
ΔΨm. Interestingly, increased ROS levels and loss of ΔΨm were also
detected in Idh2+/+ cochlea 3 days after H2O2 treatment, indicating
that an excessive amount of ROS might lead to temporary mitochon-
drial damage even in normal cells. However, 5 days after H2O2 treat-
ment, ΔΨm of Idh2+/+ hair cells was substantially restored by the en-
dogenous antioxidative system, while Idh2-deﬁcient hair cells ﬁnally
failed to survive. This means that a lack of IDH2 leads to the depolar-
ization of ΔΨm by excessive ROS, resulting in hair cell loss caused by
mitochondrial damage.
To determine the underlying cause of depolarized ΔΨm, we in-
vestigated the expression of the mitochondrial respiratory chain.
Because ΔΨm is known to be generated by the mitochondrial respiratory
chain composed of four enzyme complexes (complex I – IV), cyto-
chrome c, and ATP synthase (complex V) [28,29], changes in the ex-
pression levels of these protein complexes were examined by detecting
subunits of each complex using western blot analysis in Idh2+/+ and
Idh2−/− cochlear explants, 3 days after H2O2 treatment. The results
showed that subunits of three enzyme complexes, NDUFA9 (complex I),
UQCRC2 (complex III), and ATP5A1 (complex V), were decreased by
H2O2-induced oxidative stress, while MitoQ pre-administered hair cells
maintained intact expression of these subunits at normal levels (Fig. 7).
Particularly, although rotenone, a proven complex I inhibitor, de-
creased the NDUFA9 (complex I) expression even in the presence of
MitoQ, subsequent complex subunits (II – V) were not aﬀected by the
NDUFA9 damage. In addition, complex III inhibition by treatment of
antimycin A that is a complex III inhibitor, was prevented by MitoQ
pre-treatment (Fig. 7A). It suggests that MitoQ might have a signiﬁcant
role for maintenance of normal expression and function of electron
transport chain, as well as its antioxidative function. Eventually, ROS-
induced mitochondrial dysfunctions triggered apoptosis, and depletion
of IDH2 more strongly promoted apoptosis (Fig. 8). It suggests that the
loss of ΔΨm in hair cells lacking IDH2 was due to ROS-induced de-
gradation of mitochondrial respiratory complexes resulting in mi-
tochondrial dysfunctions and subsequent apoptosis, and that MitoQ has
a powerful protective eﬀect against mitochondrial damage through its
antioxidative activity.
Together, our ex vivo studies using cochlear explants demonstrated
that IDH2 plays a crucial role in hair cell survival by regulating mi-
tochondrial ROS levels and that hair cell degeneration caused by IDH2
deﬁciency can be surprisingly prevented by MitoQ. Therefore, Idh2−/−
mice could be used as a valuable animal model to evaluate the ther-
apeutic eﬀects of various antioxidant candidates to overcome ROS-in-
duced hearing loss.
4. Discussion
In the present study, we identiﬁed that IDH2 deﬁciency cause pro-
gressive hearing decline in mice. Excessively accumulated mitochon-
drial ROS induced depolarization of the ΔΨm, which resulted in mi-
tochondrial dysfunction leading to apoptosis of hair cells and SGNs in
Fig. 3. Detection of apoptotic cell death by TUNEL assay in the cochlea from Idh2+/+ and Idh2−/−mice. Apoptotic DNA degradation was analyzed by TUNEL
labeling (green) in Idh2+/+ and Idh2−/− mice at 10 months of age, and the nuclei were counterstained with DAPI (blue). Scale bars: 100 µm in (b′) and 20 µm in (d′
and f′).
Y.-R. Kim et al. Redox Biology 20 (2019) 544–555
549
Idh2−/− mice and their cochlear explants. Thus, IDH2 is indispensable
for the functional maintenance of mitochondria and survival of hair
cells and for the SGNs that play critical roles in the hearing pathway.
Extensive expression of IDH2 in cochlea, including hair cells and SGNs
[27], and its mitochondrial-targeted intracellular localization [27]
strongly support our results obtained in Idh2−/− mice. In particular,
the western blot analysis suggested that the most direct cause of the
decreased ΔΨm observed in Idh2−/− cochlea might be the loss of mi-
tochondrial respiratory chain complexes I, III and ATP synthase (com-
plex V). The mitochondrial respiratory chain, which consists of four
enzyme complexes (I – IV) and the ATP synthase, generates ΔΨm by
transferring protons from the mitochondrial matrix to the interspace
between the inner and outer mitochondrial membranes, and it is also
well known as a major source of superoxide (·O2-). It has been de-
monstrated that functional impairment in respiratory chain complexes
is highly linked to mitochondria-triggered apoptosis accompanied by
cytochrome c release and caspase activation [28,29]. Inhibited complex
I function led to apoptosis through caspase-3-like protease activation in
ML-1a cells and cultures of dopaminergic cells [30,31], and respiratory
chain dysfunctions induced by pathogenic gene mutations altered the
level of caspase-3 activation in response to mitochondrial stress-medi-
ated apoptotic stimuli [32]. Interestingly, each enzyme complex has
diﬀerential sensitivity to endogenous oxidative stress, and their levels
were restored by the administration of speciﬁc antioxidants. In optic
nerve head astrocytes, H2O2-induced oxidative stress signiﬁcantly in-
creased the only complexes I, II and IV, and pre-treatment with coen-
zyme Q10 preserved their expression levels at a normal state [33].
Another in vivo study using SOD2 null mice revealed that complexes I –
IV, but not V, were sensitive to mitochondrial ROS in Sod2−/− mice
[34]. Generally, protein oxidation by ROS occurs at particular amino
acid residues of a certain protein, rather than at random. Moreover,
transition metals bound to proteins are known as the strongest target of
Fig. 4. Redox status and oxidative damage observed in the inner ear of Idh2−/− mice. Intracellular levels of NADPH and ROS accumulation were compared
between Idh2+/+ and Idh2−/−mouse cochlea by immunoﬂuorescence and DAB staining at 10 months of age. (A) Intracellular NADPH (green) levels in the inner ears
of Idh2+/+ (n=3) and Idh2−/− (n=3) mice were compared at 10 months of age. COX IV (red) was used as a mitochondrial marker [32], and the nuclei were
counterstained with DAPI (blue). Scale bars: 200 µm in (c′), 100 µm in (f′) and 20 µm in (i′). (B) The enzyme activity of IDH2 that produces NADPH was measured in
the inner ear whole protein fractions (n=3). (C) Total GSH level and the [GSSG]/[GSH] ratio were measured (n=3). The values were presented as the fold change
over the levels observed in Idh2+/+ mice. Data are shown as the means ± SEM. **p < 0.005, *** p < 0.001 (D) Oxidized levels of the inner ear sections from
Idh2+/+ (n=3) and Idh2−/− (n=3) mice were analyzed using DAB staining. Scale bars: 200 µm in (a′), 100 µm in (b′) and 20 µm in (c′ and d′).
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initial oxidation, reacting with ROS and form hydroxyl radicals (·OH)
[35]. Our data suggest that only mitochondrial respiratory chain
complexes I, III and ATP synthase were particularly sensitive to oxi-
dative insult by H2O2 in hair cells lacking IDH2, which ﬁnally resulted
in apoptosis. Complex I, II and III commonly have transition metal
cofactors (iron-sulfur clusters) that are sensitive to mitochondrial ROS,
and they are functionally associated with each other [36]. Complex I
and III share important physiological characteristics. As the major
contributors of mitochondrial ROS generation,·O2- produced from
complexes I and III is converted to H2O2, which mediates intracellular
signaling under normal physiological conditions, while·O2- from com-
plex II has been proposed to be used to open mitochondrial ATP-sen-
sitive potassium channels [37]. Given the functional signiﬁcance of
respiratory complexes I, III and ATP synthase, which are responsible for
the majority of ROS and ATP synthesis, respectively, our result that
consistent downregulation of these complexes was conﬁrmed by re-
peating three independent experiments strongly suggests that IDH2
plays a critical role in maintaining mitochondrial functions and cell
Fig. 5. Evaluation of protective eﬀect of MitoQ on H2O2-induced ototoxicity in Idh2+/+ and Idh2−/− cochlear explants. (A) Immunoﬂuorescent images
represent the organ of Corti explants from each experimental group. Hair cells were stained with phalloidin (green). Scale bars: 50 µm. (B and C) Quantitative
comparison of phalloidin-positive inner and outer hair cells in Idh2+/+ and Idh2−/−mice within a 200-μm region of the organ of Corti (n=3). Data are shown as the
means± SEM. *p < 0.05, ** p < 0.005.
Fig. 6. MitoQ-mediated hair cell protection against ROS accumulation and loss of mitochondrial membrane potential caused by H2O2 insults. The organ of
Corti explants of the Idh2+/+ and Idh2−/− mice were treated with H2O2 and/or MitoQ for 3 or 5 days. (A) Level of mitochondrial ROS accumulation in the hair cells
(red) was examined using MitoSOX-red staining 3 days after H2O2 treatment. Scale bars: 50 µm. (B) Mitochondrial membrane potential was tested using MitoProbe™
JC-1 assay in the Idh2+/+ and Idh2−/− cochlea, 3 and 5 days after H2O2 treatment. Shift of the ﬂuorescence emission from green to red were detected in the cells that
are maintaining normal range of mitochondrial membrane potential. Scale bars: 50 µm.
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survival by protecting the mitochondria from the excessive ROS that
damages speciﬁc respiratory chain complexes.
The pattern of respiratory complex degeneration and loss of ΔΨm
induced by H2O2 stimuli were not IDH2-deﬁcient cell-speciﬁc defects.
Three days after H2O2 treatment, ROS-induced mitochondrial damage
did not signiﬁcantly diﬀer between Idh2+/+ hair cells and Idh2−/− hair
cells. Nevertheless, the intact function of IDH2 induced the hair cells to
restore the mitochondrial redox balance to overcome the damage, while
a lack of IDH2 eventually caused apoptotic cell death due to failure to
remove mitochondrial H2O2. However, this ROS-induced mitochondrial
damage leading to apoptosis was dramatically preserved by MitoQ in
Idh2−/− cochlea. MitoQ, an analog of ubiquinone, is a respiratory chain
component and a highly eﬀective antioxidant that prevents lipid per-
oxidation in mitochondria [38,39]. By covalent conjugation of a lipo-
philic triphenylphosphonium cation to ubiquinone, MitoQ can pass
through the phospholipid bilayers and largely accumulate into the
mitochondrial inner membrane by the ΔΨm [38]. Thus, MitoQ has been
widely used as an antioxidant that targets mitochondria [38,40]. MitoQ
is known to inhibit the ﬁnal step of lipid peroxidation by blocking ·OH
assault and is continuously recycled by returning to the active ubiquinol
form by mitochondrial respiratory chain complex II [40]. As a nontoxic
and eﬀective mitochondria-targeted antioxidant, the protective eﬀect of
MitoQ on lipid peroxidation and mitochondrial damage has been de-
termined in various studies of ROS-related diseases, including renal and
liver dysfunction in sepsis, cardiac hypertrophy, and neurodegenerative
disease [41–43]. Moreover, two previous in vivo studies found protec-
tive eﬀects of MitoQ in the inner ear. Using gentamicin- or amikacin-
treated guinea pigs, it was shown that the administration of MitoQ
attenuated aminoglycoside-induced ototoxicity, leading to cochlear
damage and hypoacusia [44,45]. Although the protective eﬀect of
MitoQ against ototoxicity was determined in previous studies, an im-
portant signiﬁcance of this study is the suggestion of the possibility to
reverse genetic hearing loss. By providing experimental evidence of the
protective potential of an antioxidant to inhibit ROS-induced cochlear
damage in a transgenic mouse model, we are the ﬁrst to suggest the
possibility that continuous application of nontoxic supplemental agents,
such as promising antioxidants, might be eﬀective in controlling the
symptoms of genetic hearing loss caused by a lack of genes involved in
the cellular redox system, although not a fundamental and direct ge-
netic correction such as virus-mediated gene transfer. In addition, al-
though all the experiment for protective eﬀect of MitoQ was veriﬁed
using ex vivo organotypic culture system of cochlea, not in vivo, cochlea
is highly distinctive organ that has structural and physiological com-
plexity, which brings diverse limits in functional investigations in vivo.
In that respect, organotypic culture of cochlear explants have strong
advantages to explore the underlying mechanisms for a particular pa-
thogenesis or development, because the cultured cochlear explants
have been proven to maintain intact conformation of the hair cells and
neuronal innervation with following normal processes of development
during it is cultured [46,47]. Importantly, most of hearing loss studies
that performed both ex vivo and in vivo experiments have shown strong
consistency in the results between these two systems [48–51], which
suggest that ex vivo studies also could provide signiﬁcant and reliable
massages.
Thus far, aging has been considered as the process of ROS-induced
damage accumulation [52], which causes mitochondrial dysfunction
resulting in age-related disorders [53]. Hearing loss caused by constant
accumulation of ROS in inner ear cells is also known to be a con-
sequence of aging; thus, the genes contributing to intracellular redox
balance have been concatenated with ARHL, i.e., presbycusis [54].
IDH2, which converts NADP+ to NADPH to maintain the GSH/GSSH
ratio, has been highlighted as the major contributor to the antioxidant
defense system in various tissues or cells [15,16,21], and several in vivo
studies found that IDH2 deﬁciency causes organ dysfunctions by
Fig. 7. Decreased expression levels of mitochondrial respiratory chain complexes in H2O2-treated cochlear explants. (A) The organ of Corti explants of the
Idh2+/+ and Idh2−/−mice were treated with H2O2 and/or MitoQ for 3 days. Altered expression levels of the oxidative phosphorylation (OXPHOS) subunits I, III and
V were detected in the total protein lysates from H2O2-treated cochlea by Western blot analysis. β-actin served as a loading control. (B) Protein levels of OXPHOS
complexes were calculated by densitometric analysis using ImageJ software (n=3) Data are shown as the means± SEM. *p < 0.05.
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mitochondrial damage with aging in old mice [23,55,56]. A recent
study performed by White et al. demonstrated that lack of IDH2 resulted
in apoptosis of hair cells and SGNs due to accumulation of mitochon-
drial oxidative stress, which accelerates ARHL in CBA/CaJ male mice.
They suggested that decreased NADPH redox status caused by IDH2
deﬁciency disables thioredoxin pathway particularly, rather than glu-
tathione pathway in mitochondria, eventually leading damages of hair
cells and SGNs [56]. This result showed two major diﬀerences with our
study, the onset age of hearing loss and its major underlying me-
chanism. First in this study, a signiﬁcant shift in the ABR threshold was
found after 3 months of age in Idh2−/− mice, which was much earlier
than the general onset age of ARHL in mice [57]. A possible explanation
can be found in the genetic background of the C57BL/6 mouse strain of
the Idh2−/− mice used in this study. The C57BL/6 mouse strain is
known as homozygous for a speciﬁc mutation in the Cdh23 gene
(c.753A>G). Because Cdh23 encodes a component of the tip-link that
connects the stereocilia of hair cells, dysfunctional CDH23 generated by
the c.753A>G mutation makes the mice susceptible to ARHL [57,58].
The C57BL/6 strain, which exhibits a critical pattern of ARHL by
12–15months of age, has been used for various studies associated with
aging [59,60]. This genetic background might accelerate the onset age
of hearing loss caused by IDH2 deﬁciency. Although this strain essen-
tially has ARHL even in wild type, the Idh2−/− mice exhibited obvious
and signiﬁcantly greater hearing deterioration and histological defects
than the Idh2+/+ mice. Moreover, only Idh2+/+ and Idh2−/− mouse
littermates were used in all experiments to minimize individual dif-
ferences and variations in the maternal environment. Therefore, we
conclude that our data are suﬃcient to provide evidence that the ob-
viously defective phenotype found in Idh2−/− mice and the disrupted
redox balance observed in IDH2-deﬁcient cochlear explants were
caused by the loss of IDH2 function. Second, our study veriﬁed that
IDH2 deﬁciency lead to an increase in the GSSG/GSH ratio leading
mitochondrial damage, suggesting that mitochondrial glutathione
pathway is signiﬁcantly regulated by IDH2. This result was highly
consistent with other IDH2 studies. In several organs, the role of IDH2
has been determined to be essential for maintenance of mitochondrial
glutathione status to prevent diseases including cardiac hypertrophy
[18], and renal dysfunction [20,61]. Considering that IDH2 is an
Fig. 8. Inhibition of apoptosis by MitoQ in H2O2-treated cochlear hair cells. Apoptotic cell death were determined by a TUNEL assay in cochlear explants of
Idh2+/+ and Idh2−/− mice. Microscopic images represent TUNEL (green) and phalloidin (red) labeled cells. Scale bars: 50 µm.
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upstream regulator of the glutathione-dependent antioxidant defense
pathway in mitochondria, it could be expected that IDH2 function
might inﬂuence the overall mitochondrial redox balance. Thus, using
this Idh2−/−mouse model for functional studies of ROS-related hearing
loss will allow us to extend the range of applicable antioxidants. This
means that various types of mitochondria-targeted antioxidant that
interventions at diﬀerent stages of the ROS cascade can be evaluated for
their therapeutic eﬀect using this valuable Idh2−/− mouse model.
In summary, our in vivo and ex vivo studies using Idh2−/− mice
demonstrated that IDH2 plays a crucial role in the survival of hair cells
and SGNs by regulating mitochondrial ROS levels, which proves the
powerful impact of IDH2 in the functional maintenance of cochlear
cells. Degeneration of the cells caused by IDH2 deﬁciency can be pre-
vented by MitoQ, suggesting a possibility that genetic hearing loss
caused by functional loss of ROS-related genes might be prevented by
nongenetic agents. Finally, this study suggests that this Idh2−/− mouse
model might be of great value in the development of novel therapeutic
agents to overcome mitochondrial ROS-induced hearing loss in humans.
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